Centro informazioni
ヤンセンが取りあげられたニュース
プレスリリース
4月 11, 2024
United States
Unique molecular properties of nipocalimab enabling differentiated potential in treating generalized myasthenia gravis to be presented at American Academy of Neurology’s 2024 Annual Meeting
4月 08, 2024
United States
Findings Presented at ACC.24 Showed XARELTO® (rivaroxaban) Reduced the Risk of Clinically Significant Bleeding and Net Adverse Clinical Events or Rehospitalization
4月 06, 2024
United States
CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy
閉じる
アートギャラリー
ヤンセンが治療と予防に携わっている病気や疾患を持つ方々のアート作品をご紹介できることを光栄に思います。
ギャラリーを見るMartin Freeman, Not What It's Cracked Up to Be